Dihydroergotamine and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Dihydroergotamine and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection)
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine-Lithium ER
- Dihydroergotamine-Lithium Oral Solution
- Dihydroergotamine-Lithium Salts
- Dihydroergotamine-Lithium Syrup and Oral Solution
- Dihydroergotamine-Lithobid
- Dihydroergotamine-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Dihydroergotamine injection
- Lithium Controlled-Release and Extended-Release Tablets-Dihydroergotamine Mesylate
- Lithium Controlled-Release and Extended-Release Tablets-Dihydroergotamine nasal
- Lithium Controlled-Release and Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Lithium Controlled-Release and Extended-Release Tablets-Dilacor XR
- Lithium Controlled-Release and Extended-Release Tablets-Dilantin